- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant IgG degrading enzyme of Streptococcus pyogene
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant IgG degrading enzyme of Streptococcus pyogenes
| EU orphan designation number: | EU/3/16/1826
|
| Active ingredient: | Recombinant IgG degrading enzyme of Streptococcus pyogenes |
| Indication: | Prevention of graft rejection following solid organ transplantation |
| Sponsor: | Hansa Medical AB
Scheelevägen 22, P.O. Box 785, SE-220 07 Lund, Sverige |
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 16/01/2017 | Orphan designation | EMA/OD/237/16 | (2017)231 of 12/01/2017 |
CONTACT
EU links
Directorate General Health & Consumers